ADAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.316600E-01
Normal-vs-Stage2
5.444400E-01
Normal-vs-Stage3
1.920410E-01
Normal-vs-Stage4
5.847400E-01
Stage1-vs-Stage2
8.700000E-01
Stage1-vs-Stage3
1.804150E-02
Stage1-vs-Stage4
2.038800E-01
Stage2-vs-Stage3
7.751400E-04
Stage2-vs-Stage4
7.885600E-02
Stage3-vs-Stage4
6.730500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.862400E-01
Normal-vs-AfricanAmerican
8.589600E-01
Normal-vs-Asian
2.274800E-01
Caucasian-vs-AfricanAmerican
1.848000E-01
Caucasian-vs-Asian
1.857820E-01
AfricanAmerican-vs-Asian
7.992400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.526000E-01
Normal-vs-Female
6.591600E-01
Male-vs-Female
2.654400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.497400E-01
Normal-vs-Age(41-60Yrs)
8.528200E-01
Normal-vs-Age(61-80Yrs)
3.970400E-01
Normal-vs-Age(81-100Yrs)
5.860000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.245800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.802000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.103400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.507500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.868200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.893000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.741400E-01
Normal-vs-Daily Drinker
1.302440E-01
Normal-vs-Weekly Drinker
4.413400E-01
Normal-vs-Occasional Drinker
8.601000E-01
Normal-vs-Social Drinker
9.176000E-01
Non Drinker-vs-Daily Drinker
2.861000E-01
Non Drinker-vs-Weekly Drinker
8.662400E-01
Non Drinker-vs-Occasional Drinker
1.452370E-01
Non Drinker-vs-Social Drinker
8.764200E-02
Daily Drinker-vs-Weekly Drinker
3.392000E-01
Daily Drinker-vs-Occasional Drinker
3.852000E-02
Daily Drinker-vs-Social Drinker
1.927770E-02
Weekly Drinker-vs-Occasional Drinker
3.422400E-01
Weekly Drinker-vs-Social Drinker
2.493000E-01
Occasional Drinker-vs-Social Drinker
8.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.970780E-01
Normal-vs-Grade 2
4.664300E-02
Normal-vs-Grade 3
5.577700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.975010E-01
Grade 1-vs-Grade 3
4.045600E-02
Grade 1-vs-Grade 4
1.970780E-01
Grade 2-vs-Grade 3
1.121830E-01
Grade 2-vs-Grade 4
4.664300E-02
Grade 3-vs-Grade 4
5.577700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.836000E-01
Normal-vs-NonDiabetic
4.005400E-01
Diabetic-vs-NonDiabetic
8.559400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.349400E-01
Normal-vs-NoPancreatitis
4.431400E-01
Pancreatitis-vs-NoPancreatitis
7.940000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.962600E-01
Normal-vs-N1
5.425000E-01
N0-vs-N1
9.467000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.249200E-01
Normal-vs-TP53-NonMutant
6.624400E-01
TP53-Mutant-vs-TP53-NonMutant
2.914600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
